Literature DB >> 21487702

Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus.

Michael S Cunnington1, Bernard Keavney.   

Abstract

Recent genome-wide association studies have demonstrated that common genetic variants in a region of chromosome 9p21 confer risk of coronary artery disease (CAD) and other atherosclerotic conditions. Although the absolute increase in risk is small (some 20-30% increase in risk of CAD per copy of the deleterious alleles), the common occurrence of the variants means that their effect on the population risk of disease is estimated to be substantial. Studies investigating the relationship between risk variants and both "classical" and "emerging" atherosclerotic risk factors have found no evidence of association. This suggests that the effect of the 9p21 locus on atherosclerotic risk is mediated via a hitherto unknown pathway potentially amenable to therapeutic modulation. Investigation of potential disease mechanisms at this locus is therefore a focus of intense interest. In this review, we discuss the progress that has been made in the study of mechanisms and highlight the outstanding research questions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487702     DOI: 10.1007/s11883-011-0178-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  48 in total

1.  Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.

Authors:  Helen M Broadbent; John F Peden; Stefan Lorkowski; Anuj Goel; Halit Ongen; Fiona Green; Robert Clarke; Rory Collins; Maria Grazia Franzosi; Gianni Tognoni; Udo Seedorf; Stephan Rust; Per Eriksson; Anders Hamsten; Martin Farrall; Hugh Watkins
Journal:  Hum Mol Genet       Date:  2007-11-29       Impact factor: 6.150

Review 2.  Long non-coding RNAs: insights into functions.

Authors:  Tim R Mercer; Marcel E Dinger; John S Mattick
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

3.  A common variant of CDKN2A (p16) predisposes to breast cancer.

Authors:  T Debniak; B Górski; T Huzarski; T Byrski; C Cybulski; A Mackiewicz; S Gozdecka-Grodecka; J Gronwald; E Kowalska; O Haus; E Grzybowska; M Stawicka; M Swiec; K Urbański; S Niepsuj; B Waśko; S Góźdź; P Wandzel; C Szczylik; D Surdyka; A Rozmiarek; O Zambrano; M Posmyk; S A Narod; J Lubinski
Journal:  J Med Genet       Date:  2005-05-06       Impact factor: 6.318

4.  A common allele on chromosome 9 associated with coronary heart disease.

Authors:  Ruth McPherson; Alexander Pertsemlidis; Nihan Kavaslar; Alexandre Stewart; Robert Roberts; David R Cox; David A Hinds; Len A Pennacchio; Anne Tybjaerg-Hansen; Aaron R Folsom; Eric Boerwinkle; Helen H Hobbs; Jonathan C Cohen
Journal:  Science       Date:  2007-05-03       Impact factor: 47.728

Review 5.  DNA damage, vascular senescence and atherosclerosis.

Authors:  Maria Grazia Andreassi
Journal:  J Mol Med (Berl)       Date:  2008-06-19       Impact factor: 4.599

6.  ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.

Authors:  Lesca M Holdt; Frank Beutner; Markus Scholz; Stephan Gielen; Gábor Gäbel; Hendrik Bergert; Gerhard Schuler; Joachim Thiery; Daniel Teupser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-07       Impact factor: 8.311

7.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

8.  Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

Authors:  Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joe Wiemels; Ping Yang; John K Wiencke
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

9.  Novel genetic variants linked to coronary artery disease by genome-wide association are not associated with carotid artery intima-media thickness or intermediate risk phenotypes.

Authors:  M S Cunnington; B M Mayosi; D H Hall; P J Avery; M Farrall; M A Vickers; H Watkins; B Keavney
Journal:  Atherosclerosis       Date:  2008-07-03       Impact factor: 5.162

10.  INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis.

Authors:  Yan Liu; Hanna K Sanoff; Hyunsoon Cho; Christin E Burd; Chad Torrice; Karen L Mohlke; Joseph G Ibrahim; Nancy E Thomas; Norman E Sharpless
Journal:  PLoS One       Date:  2009-04-03       Impact factor: 3.240

View more
  21 in total

1.  Genetics of type 2 diabetes.

Authors:  Omar Ali
Journal:  World J Diabetes       Date:  2013-08-15

Review 2.  Genome-wide studies of gene expression relevant to coronary artery disease.

Authors:  Jeffrey Hsu; Jonathan D Smith
Journal:  Curr Opin Cardiol       Date:  2012-05       Impact factor: 2.161

Review 3.  Genetics and Genomics of Coronary Artery Disease.

Authors:  Milos Pjanic; Clint L Miller; Robert Wirka; Juyong B Kim; Daniel M DiRenzo; Thomas Quertermous
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

4.  Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.

Authors:  Chao-Ling Kuo; Andrew J Murphy; Scott Sayers; Rong Li; Laurent Yvan-Charvet; Jaeger Z Davis; Janakiraman Krishnamurthy; Yan Liu; Oscar Puig; Norman E Sharpless; Alan R Tall; Carrie L Welch
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

5.  The Role of Efferocytosis in Atherosclerosis.

Authors:  Yoko Kojima; Irving L Weissman; Nicholas J Leeper
Journal:  Circulation       Date:  2017-01-31       Impact factor: 29.690

6.  Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.

Authors:  Nicholas J Leeper; Azad Raiesdana; Yoko Kojima; Ramendra K Kundu; Henry Cheng; Lars Maegdefessel; Ryuji Toh; G-One Ahn; Ziad A Ali; D Ryan Anderson; Clint L Miller; Scott C Roberts; Joshua M Spin; Patricia E de Almeida; Joseph C Wu; Baohui Xu; Karen Cheng; Maximilian Quertermous; Soumajit Kundu; Kim E Kortekaas; Erica Berzin; Kelly P Downing; Ronald L Dalman; Philip S Tsao; Eric E Schadt; Gary K Owens; Thomas Quertermous
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

7.  Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Aaron R Folsom; Vijay Nambi; James S Pankow; Weihong Tang; Kian Farbakhsh; Kazumasa Yamagishi; Eric Boerwinkle
Journal:  Atherosclerosis       Date:  2012-08-18       Impact factor: 5.162

8.  CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.

Authors:  Vivek Nanda; Kelly P Downing; Jianqin Ye; Sophia Xiao; Yoko Kojima; Joshua M Spin; Daniel DiRenzo; Kevin T Nead; Andrew J Connolly; Sonny Dandona; Ljubica Perisic; Ulf Hedin; Lars Maegdefessel; Jessie Dalman; Liang Guo; XiaoQing Zhao; Frank D Kolodgie; Renu Virmani; Harry R Davis; Nicholas J Leeper
Journal:  Circ Res       Date:  2015-11-23       Impact factor: 17.367

Review 9.  Dissecting the causal genetic mechanisms of coronary heart disease.

Authors:  Clint L Miller; Themistocles L Assimes; Stephen B Montgomery; Thomas Quertermous
Journal:  Curr Atheroscler Rep       Date:  2014-05       Impact factor: 5.113

10.  Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

Authors:  Yoko Kojima; Kelly Downing; Ramendra Kundu; Clint Miller; Frederick Dewey; Hope Lancero; Uwe Raaz; Ljubica Perisic; Ulf Hedin; Eric Schadt; Lars Maegdefessel; Tom Quertermous; Nicholas J Leeper
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.